Federal officials are moving forward with a series of White House meetings this week that could help shape how cannabidiol (CBD) products are treated under a forthcoming enforcement policy from the Food and Drug Administration. The Office of Information and Regulatory Affairs, part of the White House Office of Management and Budget, has placed four … Continue reading White House Schedules Four CBD Policy Meetings on April 1 and 2